Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Citius Pharmaceuticals, Inc.

NASDAQ: CTXR · Life Sciences · 2 alerts · CIK 1506251

Share price
$0.5276Close, Nov 16
Market cap
$14.5M
Shares outstanding
27.45MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Citius Pharmaceuticals, Inc. filings on SEC EDGAR ↗

4:32 PM ET 8-K
Clinical Trial Data

Citius Pharmaceuticals Clinical Trial Data

Citius Pharmaceuticals' subsidiary, Citius Oncology, presented health-related quality of life (HRQoL) data from its pivotal Study 302 of LYMPHIR in patients with relapsed or refractory cutaneous T-cell lymphoma. The data showed that patients who responded to the treatment reported sustained improvements in skin-related quality of life measures and significant reductions in pruritus (itching).

Counterparty
European Organisation for Research and Treatment of Cancer Cutaneous Lymphoma Tumour Group (EORTC-CLTG)

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.